These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. Bruera E, El Osta B, Valero V, Driver LC, Pei BL, Shen L, Poulter VA, Palmer JL. J Clin Oncol; 2007 Aug 10; 25(23):3475-81. PubMed ID: 17687152 [Abstract] [Full Text] [Related]
3. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL, Escalante C. J Clin Oncol; 2003 Dec 01; 21(23):4439-43. PubMed ID: 14645434 [Abstract] [Full Text] [Related]
5. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Butler JM, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1496-501. PubMed ID: 17869448 [Abstract] [Full Text] [Related]
6. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D. J Pain Symptom Manage; 2009 Nov 01; 38(5):650-62. PubMed ID: 19896571 [Abstract] [Full Text] [Related]
7. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mendonça DA, Menezes K, Jog MS. Mov Disord; 2007 Oct 31; 22(14):2070-6. PubMed ID: 17674415 [Abstract] [Full Text] [Related]
8. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Am J Med; 2006 Feb 31; 119(2):167.e23-30. PubMed ID: 16443425 [Abstract] [Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb 31; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
10. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. J Clin Psychopharmacol; 2009 Jun 31; 29(3):239-47. PubMed ID: 19440077 [Abstract] [Full Text] [Related]
15. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK. Biol Psychiatry; 2008 May 15; 63(10):981-9. PubMed ID: 18206857 [Abstract] [Full Text] [Related]
16. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM, Messina J, Xie F, Hale M. Clin Ther; 2007 Apr 15; 29(4):588-601. PubMed ID: 17617282 [Abstract] [Full Text] [Related]
17. Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial. Stone PC, Minton O, Richardson A, Buckle P, Enayat ZE, Marston L, Freemantle N. J Clin Oncol; 2024 Jul 10; 42(20):2382-2392. PubMed ID: 38757263 [Abstract] [Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P. J Clin Psychopharmacol; 2006 Dec 10; 26(6):653-6. PubMed ID: 17110825 [Abstract] [Full Text] [Related]
19. Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. Balk J, Day R, Rosenzweig M, Beriwal S. J Soc Integr Oncol; 2009 Dec 10; 7(1):4-11. PubMed ID: 19476729 [Abstract] [Full Text] [Related]